Koninklijke DSM N.V.
KDSKF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $23,450 | $38,872 | $66,045 | $49,123 |
| - Cash | $2,181 | $2,755 | $1,561 | $871 |
| + Debt | $3,118 | $3,064 | $3,093 | $3,586 |
| Enterprise Value | $24,387 | $39,181 | $67,577 | $51,838 |
| Revenue | $7,590 | $8,390 | $9,204 | $8,106 |
| % Growth | -9.5% | -8.8% | 13.5% | – |
| Gross Profit | $1,569 | $2,690 | $3,164 | $2,776 |
| % Margin | 20.7% | 32.1% | 34.4% | 34.2% |
| EBITDA | $307 | $1,376 | $1,396 | $1,433 |
| % Margin | 4% | 16.4% | 15.2% | 17.7% |
| Net Income | $2,318 | $1,700 | $1,676 | $506 |
| % Margin | 30.5% | 20.3% | 18.2% | 6.2% |
| EPS Diluted | 13.38 | 9.77 | 9.63 | 2.89 |
| % Growth | 36.9% | 1.5% | 233.2% | – |
| Operating Cash Flow | $576 | $965 | $1,427 | $1,494 |
| Capital Expenditures | -$550 | -$651 | -$577 | -$626 |
| Free Cash Flow | $26 | $314 | $850 | $868 |